AMMAN — Chief Executive Officer and Director General of the King Hussein Cancer Center (KHCC), Asem Mansour, announced Thursday that the center and the European Organization for Research and Treatment of Cancer (EORTC) had signed a cooperation agreement to advance translational and clinical
cancer research in the Middle East, according to Jordan News Agency, Petra.
اضافة اعلان
Under the agreement the KHCC will serve as a Middle East Coordinating Office (MECO) to support the organization's activities in the region.
This partnership will devote a significant portion of its efforts to developing cancer research in middle- and low-income countries, where many patients have not yet had access to clinical trials, according to a KHCC statement.
"We are thrilled to usher in a new era of clinical research in the Middle East. We are confident that we will make significant advancements in clinical trial research. Regional cooperation will help us consolidate and update all cancer diagnosis and treatment advancements. It will also allow patients to participate in clinical trials and gain access to cutting-edge new treatments that would otherwise be unavailable outside of the research environment," Mansour said.
HRH Princess Dina Mired, Honorary Chairwoman of EORTC and the Cancer Research Support Fund (ECRF), welcomed the signing of the agreement, saying, "The MECO agreement exemplifies how EORTC remains true to its mission of improving survival and quality of life for all patients." She added that access to clinical cancer research means bridging a gap in cancer treatment and care.
"We are delighted that this collaboration will allow us to expand our cancer research work in the Middle East and bring our expertise to help cancer patients in this part of the world," said Denis Lacombe, CEO of EORTC.
He stated that EORTC is a European organization with a global vision and mission to improve the lives of cancer patients worldwide, emphasizing that "the agreement with the KHCC brings us one step closer to achieving this mission."
Since 2017, the KHCC has successfully contributed to 6 clinical trials conducted by EORTC and is represented in the organization by 13 physicians and researchers representing the majority of EORTC research groups.
Read More National News
Jordan News
.jpg)
.jpg)
